Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
08 02 2020
Historique:
received: 11 12 2019
accepted: 27 01 2020
pubmed: 9 2 2020
medline: 23 1 2021
entrez: 9 2 2020
Statut: ppublish

Résumé

Alzheimer's disease (AD) is a neurodegenerative disease, where the etiology remains unclear. AD is characterized by amyloid-(Aβ) protein aggregation and neurofibrillary plaques deposits. Oxidative stress and chronic inflammation have been suggested as causes of AD. Glutamatergic pathway dysregulation is also mainly associated with AD process. In AD, the canonical WNT/β-catenin pathway is downregulated. Downregulation of WNT/β-catenin, by activation of GSK-3β-induced Aβ, and inactivation of PI3K/Akt pathway involve oxidative stress in AD. The downregulation of the WNT/β-catenin pathway decreases the activity of EAAT2, the glutamate receptors, and leads to neuronal death. In AD, oxidative stress, neuroinflammation and glutamatergic pathway operate in a vicious circle driven by the dysregulation of the WNT/β-catenin pathway. Riluzole is a glutamate modulator and used as treatment in amyotrophic lateral sclerosis. Recent findings have highlighted its use in AD and its potential increase power on the WNT pathway. Nevertheless, the mechanism by which Riluzole can operate in AD remains unclear and should be better determine. The focus of our review is to highlight the potential action of Riluzole in AD by targeting the canonical WNT/β-catenin pathway to modulate glutamatergic pathway, oxidative stress and neuroinflammation.

Identifiants

pubmed: 32035419
doi: 10.18632/aging.102830
pii: 102830
pmc: PMC7041777
doi:

Substances chimiques

Neuroprotective Agents 0
Wnt Proteins 0
beta Catenin 0
Riluzole 7LJ087RS6F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3095-3113

Références

Nature. 2000 Jul 6;406(6791):86-90
pubmed: 10894547
J Neuroinflammation. 2016 Sep 10;13(1):242
pubmed: 27612942
Glia. 2015 Sep;63(9):1568-80
pubmed: 25880604
J Biol Chem. 2009 Oct 2;284(40):27438-48
pubmed: 19657144
Neuroimmunomodulation. 2012;19(2):121-30
pubmed: 22248728
Prog Brain Res. 2002;136:467-86
pubmed: 12143403
Oncogene. 2002 Nov 28;21(54):8293-301
pubmed: 12447692
Neuroscientist. 2002 Oct;8(5):497-511
pubmed: 12374432
Neuron. 2011 Dec 22;72(6):1012-24
pubmed: 22196336
Front Cell Neurosci. 2013 Jul 04;7:103
pubmed: 23847469
PLoS One. 2011 Apr 26;6(4):e19191
pubmed: 21541279
J Physiol. 2006 Apr 15;572(Pt 2):477-92
pubmed: 16469784
Mol Neurobiol. 2013 Dec;48(3):438-51
pubmed: 23494748
J Cell Mol Med. 2016 Apr;20(4):601-12
pubmed: 26828721
Trends Mol Med. 2007 Nov;13(11):460-9
pubmed: 18029230
Nat Rev Cancer. 2012 Nov;12(11):741-52
pubmed: 23018234
Neurol Clin. 2000 Nov;18(4):829-46
pubmed: 11072263
Nat Rev Neurosci. 2010 Aug;11(8):539-51
pubmed: 20648061
J Alzheimers Dis. 2010;20 Suppl 2:S499-512
pubmed: 20413847
PLoS One. 2016 Mar 31;11(3):e0152833
pubmed: 27031698
J Mol Cell Biol. 2014 Feb;6(1):64-74
pubmed: 24549157
Aging (Albany NY). 2015 Dec;7(12):1094-111
pubmed: 26647069
Neurochem Int. 2013 Dec;63(7):670-81
pubmed: 23791709
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
J Exp Clin Cancer Res. 2019 Jul 22;38(1):323
pubmed: 31331376
Acta Biochim Biophys Sin (Shanghai). 2017 Oct 1;49(10):853-866
pubmed: 28981597
Arch Toxicol. 2015 Oct;89(10):1669-80
pubmed: 26126631
J Proteome Res. 2013 Jun 7;12(6):2654-65
pubmed: 23550703
Front Mol Neurosci. 2012 Jan 30;5:1
pubmed: 22319467
Oxid Med Cell Longev. 2014;2014:497802
pubmed: 24683436
Neuromolecular Med. 2010 Mar;12(1):1-12
pubmed: 20232515
Neurobiol Aging. 2005 Oct;26(9):1235-44
pubmed: 16023263
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206
pubmed: 13129806
Curr Opin Drug Discov Devel. 2010 Sep;13(5):595-603
pubmed: 20812151
Neuron. 2003 Jul 3;39(1):43-56
pubmed: 12848931
Biomed Res Int. 2013;2013:484613
pubmed: 24455696
Nat Rev Mol Cell Biol. 2009 Jul;10(7):468-77
pubmed: 19536106
J Alzheimers Dis. 2007 Mar;11(1):97-116
pubmed: 17361039
Curr Med Chem. 2018;25(40):5578-5587
pubmed: 28618998
J Neurosci. 2011 May 4;31(18):6627-38
pubmed: 21543591
Cell. 2010 Mar 19;140(6):918-34
pubmed: 20303880
Mol Psychiatry. 2010 Nov;15(11):1046-52
pubmed: 20966918
Curr Neurovasc Res. 2009 Feb;6(1):20-31
pubmed: 19355923
Life Sci. 2018 Jan 15;193:141-152
pubmed: 29079469
Trends Mol Med. 2001 Dec;7(12):548-54
pubmed: 11733217
Development. 2015 Mar 1;142(5):972-82
pubmed: 25715397
Front Neurol. 2016 Jun 28;7:100
pubmed: 27445967
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7
pubmed: 10318916
Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001447
pubmed: 22419278
Cell. 1999 Mar 19;96(6):857-68
pubmed: 10102273
Nature. 2001 May 17;411(6835):321-5
pubmed: 11357136
Front Cell Dev Biol. 2016 Nov 30;4:138
pubmed: 27965955
Chem Biol. 2010 Nov 24;17(11):1177-82
pubmed: 21095567
J Neurochem. 2015 Oct;135(2):207-9
pubmed: 26451974
Nat Neurosci. 2012 Jan 29;15(3):349-57
pubmed: 22286176
Brain Res. 2010 Dec 17;1366:27-37
pubmed: 20969832
EMBO J. 1997 Jul 1;16(13):3797-804
pubmed: 9233789
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12893-900
pubmed: 10536019
Neurol Res. 2017 Jan;39(1):73-82
pubmed: 27809706
J Biol Chem. 2009 Aug 14;284(33):22274-84
pubmed: 19497850
Alzheimers Dement. 2007 Jul;3(3):186-91
pubmed: 19595937
Cell. 2009 Oct 16;139(2):285-98
pubmed: 19837032
Biomed Res Int. 2014;2014:301575
pubmed: 24883305
Mitochondrion. 2013 Jul;13(4):298-311
pubmed: 23562762
Front Neurosci. 2016 Oct 19;10:459
pubmed: 27807401
Genesis. 2010 Feb;48(2):86-95
pubmed: 20027618
Arch Neurol. 2002 Jun;59(6):972-6
pubmed: 12056933
Clin Chem. 2006 Apr;52(4):601-23
pubmed: 16484333
Front Mol Neurosci. 2017 Dec 19;10:427
pubmed: 29311817
Dev Cell. 2015 Jan 12;32(1):82-96
pubmed: 25584796
Antioxid Redox Signal. 2007 Aug;9(8):1115-24
pubmed: 17567242
Front Immunol. 2017 Feb 24;8:187
pubmed: 28286503
Med Sci (Paris). 2018 Apr;34(4):326-330
pubmed: 29658475
Glia. 2010 Feb;58(3):253-63
pubmed: 19705460
FASEB J. 2002 Oct;16(12):1526-36
pubmed: 12374775
PLoS One. 2012;7(10):e46885
pubmed: 23056511
Neurobiol Dis. 2005 Nov;20(2):392-400
pubmed: 16242644
Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12
pubmed: 17245412
Ann N Y Acad Sci. 2008 Dec;1147:180-95
pubmed: 19076441
Eur J Pharm Sci. 2011 Apr 18;42(5):540-6
pubmed: 21352912
Oxid Med Cell Longev. 2015;2015:604658
pubmed: 26543520
Trends Biochem Sci. 2010 Mar;35(3):161-8
pubmed: 19884009
J Biol Chem. 1997 Jul 25;272(30):18779-89
pubmed: 9228052
Pancreas. 2008 Jan;36(1):80-3
pubmed: 18192886
Nat Rev Cancer. 2008 May;8(5):387-98
pubmed: 18432252
Mol Cell Biol. 2002 Nov;22(22):7842-52
pubmed: 12391153
J Neurochem. 2015 Oct;135(2):381-94
pubmed: 26146790
Nat Rev Neurosci. 2008 Jan;9(1):65-75
pubmed: 18094707
Neurology. 1996 Dec;47(6 Suppl 4):S233-41
pubmed: 8959995
Neurobiol Dis. 2008 Jun;30(3):331-42
pubmed: 18420416
Trends Endocrinol Metab. 2005 May-Jun;16(4):183-9
pubmed: 15860415
Antioxid Redox Signal. 2006 May-Jun;8(5-6):929-47
pubmed: 16771683
Alzheimers Dement. 2011 Mar;7(2):175-6
pubmed: 21414555
J Immunol. 2011 Jun 15;186(12):6771-8
pubmed: 21562161
Nucleic Acids Res. 1999 Aug 1;27(15):3213-8
pubmed: 10454620
Expert Rev Mol Med. 2011 Jun 20;13:e21
pubmed: 21682951
Front Immunol. 2016 Sep 22;7:378
pubmed: 27713747
Mol Brain. 2018 Jan 4;11(1):1
pubmed: 29301575
Cell Signal. 2010 Sep;22(9):1317-29
pubmed: 20462515
J Virol. 2012 Feb;86(4):1911-21
pubmed: 22156527
Synapse. 2009 Mar;63(3):206-14
pubmed: 19072840
Eur Heart J. 2011 Nov;32(22):2841-50
pubmed: 21398644
J Neuroimmune Pharmacol. 2012 Dec;7(4):725-30
pubmed: 23114888
Neuromolecular Med. 2018 Jun;20(2):174-204
pubmed: 29572723
Nat Rev Drug Discov. 2011 Oct 21;10(11):853-67
pubmed: 22015920
Curr Opin Genet Dev. 2010 Feb;20(1):51-6
pubmed: 19942427
Nat Neurosci. 2005 Aug;8(8):1051-8
pubmed: 16025111
Front Immunol. 2018 Apr 13;9:745
pubmed: 29706964
Rev Neurosci. 2018 Jul 26;29(5):547-555
pubmed: 29303786
Neuron. 2003 Mar 27;37(6):925-37
pubmed: 12670422
Neurotox Res. 2013 Apr;23(3):267-300
pubmed: 22739839
Front Cell Neurosci. 2013 Jun 25;7:97
pubmed: 23805073
J Alzheimers Dis. 2011;23(2):195-206
pubmed: 20930307
J Alzheimers Dis. 2001 Feb;3(1):75-80
pubmed: 12214075
Ageing Res Rev. 2013 Jun;12(3):786-800
pubmed: 23665425
Organogenesis. 2008 Apr;4(2):60-7
pubmed: 19122781
N Engl J Med. 1994 Mar 3;330(9):585-91
pubmed: 8302340
Cold Spring Harb Perspect Biol. 2013 Mar 01;5(3):a015081
pubmed: 23085770
J Clin Invest. 2014 Sep;124(9):3825-46
pubmed: 25083995
FEBS Lett. 2008 Jan 23;582(2):359-64
pubmed: 18174027
Neurotherapeutics. 2008 Oct;5(4):516-27
pubmed: 19019302
Nat Cell Biol. 2012 Dec;14(12):1295-304
pubmed: 23178880
PLoS One. 2013 Dec 04;8(12):e81158
pubmed: 24324671
Am J Psychiatry. 1982 Sep;139(9):1136-9
pubmed: 7114305
Trends Immunol. 2010 Jan;31(1):24-31
pubmed: 19836308
Brain Behav Immun. 2016 Jul;55:225-235
pubmed: 26593276
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4129-34
pubmed: 21325052
Annu Rev Cell Dev Biol. 2004;20:781-810
pubmed: 15473860
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18733-8
pubmed: 25512503
Brain. 1996 Dec;119 ( Pt 6):2001-7
pubmed: 9010004
Mediators Inflamm. 2014;2014:310183
pubmed: 25136145
Cell Physiol Biochem. 2015;35(2):419-32
pubmed: 25613036
Mol Psychiatry. 2017 Feb;22(2):296-305
pubmed: 27021815
Biochem Soc Trans. 2007 Nov;35(Pt 5):1119-21
pubmed: 17956292
J Neurosci. 2004 Jun 30;24(26):6021-7
pubmed: 15229249
J Biol Chem. 2008 Apr 4;283(14):9224-30
pubmed: 18250171
J Neurochem. 2003 Jun;85(6):1394-401
pubmed: 12787059
Lancet. 1996 May 25;347(9013):1425-31
pubmed: 8676624
Open Ophthalmol J. 2014 Jul 23;8:39-47
pubmed: 25191529
Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
pubmed: 20840865
J Biol Chem. 2011 Jul 1;286(26):23063-76
pubmed: 21550980
J Neurochem. 2016 Oct;139 Suppl 1:216-231
pubmed: 27546335
Cancer Cell. 2002 Oct;2(4):323-34
pubmed: 12398896
J Physiol. 2000 Nov 15;529 Pt 1:57-68
pubmed: 11080251
Lancet. 1994 Sep 17;344(8925):769-72
pubmed: 7916070
Cell Death Dis. 2013 Jun 13;4:e673
pubmed: 23764854
Transl Psychiatry. 2018 Mar 6;8(1):55
pubmed: 29507296
Mutat Res. 2002 Apr 25;501(1-2):105-13
pubmed: 11934442
Front Physiol. 2017 May 30;8:352
pubmed: 28620312
Future Med Chem. 2012 Sep;4(13):1689-700
pubmed: 22924507
Life Sci. 2016 Aug 1;158:78-88
pubmed: 27370940
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2037-42
pubmed: 20133848
Mol Carcinog. 2004 Mar;39(3):139-46
pubmed: 14991743
Ann Neurol. 2011 Oct;70(4):532-40
pubmed: 22028219
J Immunol. 2002 May 15;168(10):5024-31
pubmed: 11994454
J Ethnopharmacol. 2016 Feb 17;179:162-9
pubmed: 26721223
Prog Nucleic Acid Res Mol Biol. 2001;70:33-75
pubmed: 11642366
Curr Issues Mol Biol. 2019;31:21-44
pubmed: 31160540
Science. 2005 May 20;308(5725):1181-4
pubmed: 15905404
Biochim Biophys Acta. 2004 Dec 6;1742(1-3):81-7
pubmed: 15590058
Exp Cell Res. 2004 Jul 15;297(2):424-33
pubmed: 15212945
CNS Drugs. 2008;22(9):761-86
pubmed: 18698875
Mol Cell Biol. 2004 Nov;24(22):10058-71
pubmed: 15509806
J Alzheimers Dis. 2018;64(s1):S547-S554
pubmed: 29758944
Brain Pathol. 2015 Nov;25(6):679-91
pubmed: 25351914
J Biol Chem. 2012 Oct 26;287(44):37245-58
pubmed: 22948140
Cells. 2019 Jul 15;8(7):
pubmed: 31311204
J Alzheimers Dis. 2017;55(4):1307-1320
pubmed: 27858715
Neuron. 2009 Jul 30;63(2):178-88
pubmed: 19640477
J Biol Chem. 1997 May 30;272(22):14426-33
pubmed: 9162082
CNS Neurol Disord Drug Targets. 2013 Sep;12(6):870-81
pubmed: 23469836
Antioxid Redox Signal. 2005 Sep-Oct;7(9-10):1140-9
pubmed: 16115017
Brain Behav Immun. 1995 Dec;9(4):355-65
pubmed: 8903852
Neurosci Lett. 2003 Dec 26;353(3):185-8
pubmed: 14665412
Mol Cell. 2011 Jun 24;42(6):719-30
pubmed: 21700219
Biogerontology. 2014 Dec;15(6):559-77
pubmed: 25305052
Biochem Soc Trans. 2010 Aug;38(4):967-72
pubmed: 20658986

Auteurs

Alexandre Vallée (A)

DACTIM-MIS, Laboratory of Mathematics and Applications (LMA), University of Poitiers, CHU de Poitiers, Poitiers, France.

Jean-Noël Vallée (JN)

CHU Amiens Picardie, University of Picardie Jules Verne (UPJV), Amiens, France.
Laboratory of Mathematics and Applications (LMA), University of Poitiers, Poitiers, France.

Rémy Guillevin (R)

DACTIM-MIS, Laboratory of Mathematics and Applications (LMA), University of Poitiers, CHU de Poitiers, Poitiers, France.

Yves Lecarpentier (Y)

Centre de Recherche Clinique, Grand Hôpital de l'Est Francilien (GHEF), Meaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH